Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

P.-Y. Lévy Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract A. Torres-Cornejo, O.J.

Circulating levels of sTNFR and discrepancy between cytotoxicity and immunoreactivity of TNF-α in patients with visceral leishmaniasis I.M. Medeiros,

C. Steininger, M. Redlberger, W. Graninger, M. Kundi, T. Popow-Kraupp

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Infectious causes of cancer: an evolving educational saga

Virological tools to diagnose and monitor hepatitis C virus infection

The microarray technology: facts and controversies

R. Cantón Clinical Microbiology and Infection

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.

Vector control: a cornerstone in the malaria elimination campaign

The role of vaccination in preventing pneumococcal disease in adults

L. Gatta, C. Ricci, A. Tampieri, D. Vaira

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

Detection of human metapneumovirus and respiratory syncytial virus by duplex real-time RT-PCR assay in comparison with direct fluorescent assay P. Jokela,

B. Gordts Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

V Duque, ÁA. Holguín, M. Silvestre, J. GonzÁAlez-Lahoz, V. Soriano

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Hepatitis B and C virus-related carcinogenesis

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Pathogenesis of catheter-related infections: lessons for new designs

R. Colebunders, P. Michielsen Clinical Microbiology and Infection

New developments in laboratory monitoring of HIV-1 infection

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Training in infectious diseases and tropical medicine in Britain

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

Fibronectin concentrations in catheter sepsis

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Clinical infection services—the Leiden experience

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Overview of cefixime use in community-acquired infections

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

High prevalence of GB virus C/hepatitis G virus infection in different risk groups of HIV- infected patients P. Clevenbergh, J. Durant, P. Halfon, A.

J.L. Balcázar Clinical Microbiology and Infection

Typing of Clostridium difficile

New patterns of HIV-1 resistance during HAART

Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies J.C. Martín, V Soriano,

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Vincent Calvez, Marc Grandadam Clinical Microbiology and Infection

Presentation transcript:

Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories G. Muyldermans, L. Debaisieux, K. Fransen, D. Marissens, K. Miller, D. Vaira, A.-M. Vandamme, A.-T. Vandenbroucke, C. Verhofstede, R. Schuurman, G. Zissis, S. Lauwers Clinical Microbiology and Infection Volume 6, Issue 4, Pages 213-217 (April 2000) DOI: 10.1046/j.1469-0691.2000.00048.x Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Correlation between the mean HIV-1 RNA levels as measured with the HIV-1 Monitor version 1.5 assay and the dilution factor of the samples. The dashed line represents the lower limit of detection. Correlation: −0.998, slope: − 0.930. Clinical Microbiology and Infection 2000 6, 213-217DOI: (10.1046/j.1469-0691.2000.00048.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions